Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001677036-25-000004
Filing Date
2025-10-02
Accepted
2025-10-02 16:23:28
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3960
  Complete submission text file 0001677036-25-000004.txt   5533
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Lind Kevin Robert (Reporting) CIK: 0001677036 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 251369500